Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty
Clinical trial NCT05139030 · COMPLETED
Trial details
- NCT number
- NCT05139030
- Sponsor
- Pacira Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2022-07-11
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.